Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: J Steroid Biochem Mol Biol. 2010 Mar 19;121(1-2):408–412. doi: 10.1016/j.jsbmb.2010.03.053

Figure 2. Effects of the Gemini vitamin D analog BXL0124 on mammary tumorigenesis in MMTV-ErbB2/neu transgenic mice.

Figure 2

The MMTV-ErbB2/neu transgenic mice were treated with vehicle or BXL0124 (0.3 μg/kg body weight) intraperitoneally three times a week starting at the 4 months of age until the age of 54 weeks. The number of mice in the control and BXL0124-treated groups were 16 and 8, respectively. The tumor volume was measured weekly up to 54 weeks. A. The average body weight. B. The average tumor volume (cm3). C. The average tumor weight (gram). D. The average tumor multiplicity. E. Serum calcium level (Statistical significance, *p<0.05).